tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

LGVN Stock Latest News

Longeveron granted Japan patent for potency assay methods for MSCs
The FlyLongeveron granted Japan patent for potency assay methods for MSCs
1d ago
LGVN
Longeveron granted FDA Type C Meeting ahead of ELPIS II data readout
PremiumThe Fly
Longeveron granted FDA Type C Meeting ahead of ELPIS II data readout
4d ago
LGVN
Longeveron granted U.S. patent for method of treating female sexual dysfunction
PremiumThe Fly
Longeveron granted U.S. patent for method of treating female sexual dysfunction
1M ago
LGVN
Longeveron granted Canadian patent covering laromestrocel administration
PremiumThe Fly
Longeveron granted Canadian patent covering laromestrocel administration
2M ago
LGVN
Longeveron to present MRI biomarker data in Alzheimer’s at CTAD 2025
PremiumThe Fly
Longeveron to present MRI biomarker data in Alzheimer’s at CTAD 2025
2M ago
LGVN
Longeveron granted U.S. patent for administration of MSCs
PremiumThe FlyLongeveron granted U.S. patent for administration of MSCs
3M ago
LGVN
Longeveron Announces Resignation of Board Members
Premium
Company Announcements
Longeveron Announces Resignation of Board Members
3M ago
8K
LGVN
Longeveron: Promising Outlook with Clinical Progress and Strategic Adjustments
Premium
Ratings
Longeveron: Promising Outlook with Clinical Progress and Strategic Adjustments
3M ago
LGVN
Longeveron Inc. Earnings Call: Mixed Sentiments Amid Clinical Progress
PremiumCompany Announcements
Longeveron Inc. Earnings Call: Mixed Sentiments Amid Clinical Progress
3M ago
LGVN
Longeveron Inc. Reports Q3 2025 Financial Results
PremiumCompany Announcements
Longeveron Inc. Reports Q3 2025 Financial Results
3M ago
LGVN
Longeveron reports Q3 EPS (39c), consensus (26c)
PremiumThe Fly
Longeveron reports Q3 EPS (39c), consensus (26c)
3M ago
LGVN
Longeveron Inc. (LGVN) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
Longeveron Inc. (LGVN) Q3 Earnings Cheat Sheet
3M ago
LGVN
Longeveron Appoints Dr. George Paletta to Board
PremiumCompany AnnouncementsLongeveron Appoints Dr. George Paletta to Board
4M ago
8K
LGVN
Longeveron Faces Nasdaq Delisting Notice for Stock Price
Premium
Company Announcements
Longeveron Faces Nasdaq Delisting Notice for Stock Price
4M ago
8K
LGVN
Longeveron Announces Leadership Changes Amidst CEO Departure
Premium
Company Announcements
Longeveron Announces Leadership Changes Amidst CEO Departure
5M ago
8K
LGVN
Longeveron CEO Wa’el Hashad to step down
PremiumThe Fly
Longeveron CEO Wa’el Hashad to step down
5M ago
LGVN
Longeveron Inc. Earnings Call: Progress Amid Challenges
PremiumCompany Announcements
Longeveron Inc. Earnings Call: Progress Amid Challenges
5M ago
LGVN
Longeveron: Buy Rating Backed by Promising Clinical Developments and Strategic Financial Outlook
PremiumRatings
Longeveron: Buy Rating Backed by Promising Clinical Developments and Strategic Financial Outlook
6M ago
LGVN
Longeveron price target lowered to $3 from $10 at Roth Capital
PremiumThe Fly
Longeveron price target lowered to $3 from $10 at Roth Capital
6M ago
LGVN
Longeveron Inc. Faces Regulatory and Manufacturing Challenges Threatening Financial Stability
PremiumCompany AnnouncementsLongeveron Inc. Faces Regulatory and Manufacturing Challenges Threatening Financial Stability
6M ago
LGVN
Longeveron Inc. Reports Q2 2025 Financial Results
Premium
Company Announcements
Longeveron Inc. Reports Q2 2025 Financial Results
6M ago
LGVN
Longeveron Closes $5 Million Public Stock Offering
Premium
Company Announcements
Longeveron Closes $5 Million Public Stock Offering
6M ago
8K
LGVN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >